
China - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Containing Penicillin Prices in China
China Medicaments Containing Penicillin Export Price in April 2022
In April 2022, the medicaments containing penicillin price stood at $143 per kg (FOB, China), with a decrease of -7.9% against the previous month. In general, the export price continues to indicate a slight decline. The most prominent rate of growth was recorded in March 2022 when the average export price increased by 9.6% m-o-m. As a result, the export price attained the peak level of $155K per ton, and then contracted in the following month.
There were significant differences in the average prices for the major export markets. In April 2022, the country with the highest price was Romania ($260 per kg), while the average price for exports to Algeria ($48.9 per kg) was amongst the lowest.
From January 2022 to April 2022, the most notable rate of growth in terms of prices was recorded for supplies to Mexico (+33.5%), while the prices for the other major destinations experienced more modest paces of growth.
China Medicaments Containing Penicillin Exports
In April 2022, medicaments containing penicillin exports from China soared to 42 tons, jumping by 38% on the previous month. Overall, exports, however, showed a relatively flat trend pattern. Over the period under review, the exports hit record highs at 42 tons in January 2022; afterwards, it flattened through to April 2022.
In value terms, medicaments containing penicillin exports surged to $6M (IndexBox estimates) in April 2022. Over the period under review, exports, however, saw a mild setback. The most prominent rate of growth was recorded in March 2022 when exports increased by 42% m-o-m. The exports peaked at 6.2K tons in January 2022; however, from February 2022 to April 2022, the exports stood at a somewhat lower figure.
China Medicaments Containing Penicillin Exports by Country
Egypt (9 tons), Romania (4.5 tons) and Algeria (4 tons) were the main destinations of medicaments containing penicillin exports from China, together comprising 42% of total exports. Moreover, medicaments containing penicillin exports in Egypt exceeded the figures recorded by the second-largest exporter, Romania, twofold.
From January 2022 to April 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Algeria (with a CAGR of +321.1%), while the other leaders experienced more modest paces of growth.
In value terms, Romania ($1.2M), Egypt ($915K) and South Korea ($615K) appeared to be the largest markets for medicaments containing penicillin exported from China worldwide, with a combined 45% share of total exports.
Among the main countries of destination, Egypt, with a CAGR of +37.2%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
This report provides an in-depth analysis of the medicaments containing penicillin market in China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201130 - Medicaments containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives, for therapeutic or prophylactic uses, n.p.r.s.
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORTS
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country, 2012–2024
This report provides an in-depth analysis of the medicaments containing penicillin market in China.
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in China.
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in China.
This report provides an in-depth analysis of the market for medicaments of other antibiotics in China.
This report provides an in-depth analysis of the medicaments containing hormones market in China.
This report provides an in-depth analysis of the medicaments containing insulin market in China.
This report provides an in-depth analysis of the global medicaments containing penicillin market.
This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.
This report provides an in-depth analysis of the global market for medicaments of other antibiotics.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.